查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1609967

血漿分餾市場規模、佔有率、趨勢分析報告：按產品、方法、應用、最終用途、地區和細分市場預測，2025-2030 年

Plasma Fractionation Market Size, Share & Trends Analysis Report By Product (Immunoglobulins, Coagulation Factors), By Method (Chromatography, Centrifugation), By Application, By End-use, By Region, And Segment Forecasts, 2025 - 2030
出版日期: | 出版商: Grand View Research | 英文 120 Pages | 商品交期: 2-10個工作天內

價格

血漿分餾市場成長與趨勢：

根據 Grand View Research, Inc. 的最新報告，預計到 2030 年，全球血漿分餾市場規模將達到 582.4 億美元，並且預計 2025 年至 2030 年複合年成長率為 8.5%。

推動市場成長的主要因素是全球呼吸系統疾病、血液相關疾病的盛行率上升，以及更容易罹患各種罕見疾病的人口老化。這些都是市場拓展的主要因素。此外，需要血漿治療和衍生物的罕見疾病的盛行率不斷上升也補充了市場的成長。

此外，免疫球蛋白和α-1-抗胰蛋白酶目前正被用於世界各地的各個研究領域，為全球市場的擴張做出了貢獻。市場擴張的另一個重要因素是全球採血設施的增加。例如，根據世界衛生組織統計，截至2022年5月，全球已有超過1.18億人捐血，血漿供應量逐漸增加。此外，政府提高民眾對血漿衍生產品使用意識的支持措施也是全球市場擴張的主要動力。

血漿輸注是治療 COVID-19 感染的最先進治療之一。例如，2020 年 8 月，美國食品藥物管理局(USFDA) 向 COVID-19 恢復期血漿療法授予緊急使用核准(EUA)。此外，2021 年 2 月，我們宣布了一項關於針對 COVID-19 的血漿 EUA 的修訂指令。因此，在 COVID-19 大流行期間，血漿分餾技術的使用預計會增加。

由於個人化治療的需求不斷成長，研發成本不斷增加，而免疫血清球蛋白等血漿成分的技術進步，具有產量高、成本低、通量快等優勢，是增加市場的驅動力。 。另一方面，由血漿產生的免疫球蛋白更頻繁地用於各種臨床病症，包括自體免疫疾病和發炎性疾病。胞漿素、IgA 和胞漿素等治療藥物已從血漿分餾領域獲得了大量資金。此外，該行業正在受到創新和技術開發投資增加的推動，這些投資提供了高效且廉價的蛋白質分離方法。

這個市場為企業開展市場相關業務提供了許多機會。此外，隨著市場的穩定擴大，全球各地區的市場參與企業在積極實施有機和無機的發展策略。因此，預計市場在預測期內將吸引更多引人注目的投資。例如，2022 年 1 月，Biotest AG 在捷克共和國開設了第八個血漿採集設施。該國公共衛生當局 SUKL 已授予該公司經營這些中心的許可證。

血漿分餾市場報告亮點

  • 免疫球蛋白領域預計將在 2024 年以 63.2% 的收益佔有率主導市場，並以 9.1% 的複合年成長率成長最快。
  • 層析法細分市場佔據主導地位，到 2024 年，其佔有率將達到 33.7%。血漿分餾的精製技術以及工業規模層析法分離的使用最近有所增加。
  • 由於人們對神經系統疾病血漿衍生療法的認知不斷提高，神經學領域在 2024 年佔據了最大的銷售佔有率，達到 30.0%。多發性硬化症、Guillain-Barré二氏症候群和慢性脫髓鞘多發性神經炎等疾病擴大採用靜脈免疫球蛋白療法 (IVIg) 和血漿置換等療法進行治療。
  • 醫院和診所在2024年佔據市場主導地位，收益佔有率53.4%，預計在預測期內將以9.0%的最快複合年成長率成長。這是由於各種醫療應用對血漿衍生療法的需求不斷成長所推動的。

目錄

第1章調查方法和範圍

第 2 章執行摘要

第 3 章血漿分餾市場變數、趨勢、範圍

  • 市場體系展望
    • 母市場展望
    • 相關/附隨市場展望
  • 市場動態
    • 市場推動要素分析
    • 市場限制因素分析
  • 血漿分餾市場分析工具
    • 產業分析-波特五力分析
    • PESTEL分析
    • COVID-19 影響分析

第 4 章血漿分餾市場：按產品分類的估計和趨勢分析

  • 細分儀表板
  • 全球血漿分餾市場產品波動分析
  • 2018-2030 年全球血漿分餾市場規模及趨勢分析（依產品）
  • 白蛋白
  • 免疫球蛋白
    • 靜脈注射免疫球蛋白
    • 皮下注射免疫球蛋白
    • 其他免疫球蛋白
  • 凝血因子
    • 因子VIII
    • 因子IX
    • 血管性血友病因子
    • 凝血酶原複合物濃縮物
    • 纖維蛋白原濃縮物
    • 其他
  • 蛋白酶抑制劑
  • 其他

第5章血漿分餾市場：方法估計與趨勢分析

  • 細分儀表板
  • 全球血漿分餾市場波動分析
  • 2018-2030 年全球血漿分餾市場規模及趨勢分析（依方法）
  • 離心
  • 深層過濾
  • 層析法
  • 其他

第6章血漿分餾市場：依應用估算與趨勢分析

  • 細分儀表板
  • 全球血漿分餾市場應用變遷分析
  • 2018-2030 年全球血漿分餾市場規模及趨勢分析（依應用）
  • 神經病學
  • 血液學
  • 腫瘤學
  • 免疫學
  • 呼吸系統醫療設備
  • 其他

第7章血漿分餾市場：最終用途的估計和趨勢分析

  • 細分儀表板
  • 全球血漿分餾市場的最終用途變化分析
  • 2018-2030 年全球血漿分餾市場規模與趨勢分析（依最終用途）
  • 醫院/診所
  • 臨床調查
  • 其他

第8章血漿分餾市場：區域估計和趨勢分析

  • 2024 年及 2030 年區域市場佔有率分析
  • 區域市場儀表板
  • 2018-2030年市場規模及預測趨勢分析：
  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 丹麥
    • 瑞典
    • 挪威
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 韓國
    • 泰國
  • 拉丁美洲
    • 巴西
    • 阿根廷
  • 中東/非洲
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 科威特

第9章 競爭格局

  • 公司/競爭對手分類
  • 策略規劃
  • 2024 年企業市場分析
  • 公司簡介
    • Grifols SA
    • CSL Limited
    • Takeda Pharmaceutical Company Limited
    • Octapharma AG
    • Kedrion SpA
    • LFB SA
    • Biotest AG
    • Sanquin
    • Bio Products Laboratory Ltd.
    • Intas Pharmaceuticals Ltd
Product Code: GVR-4-68039-962-8

Plasma Fractionation Market Growth & Trends:

The global plasma fractionation market size is estimated to reach USD 58.24 billion by 2030, registering to grow at a CAGR of 8.5% from 2025 to 2030 according to a new report by Grand View Research, Inc. The major factors driving the market growth are the rising prevalence of respiratory illnesses globally, blood-related diseases, and an aging population that is prone to a variety of rare disorders. These are the main drivers of market expansion. In addition, the rise in the prevalence of rare disorders that call for plasma therapy or derivatives also supplemented the market growth.

The global market is also expanding due to the increased use of immunoglobulins as well as alpha-1-antitrypsin in various areas of research around the world. Another important factor for the expansion of the market is the rise in blood collection facilities globally. For instance, as per the WHO, as of May 2022, over 118 million blood donations were collected across the globe, thus increasing the plasma supply gradually. Additionally, supportive government initiatives to raise public awareness about the usage of plasma-derived products also serve as a major driver of the global market's expansion.

Blood plasma transfusions are one of the cutting-edge treatments for COVID-19 infection. For instance, in August 2020, the US Food and Drug Administration (USFDA) granted the convalescent plasma treatment of COVID-19 an emergency use authorization (EUA). Additionally, in February 2021, it published an amended directive for the plasma EUA for COVID-19. As a result, the usage of plasma fractionation technologies is projected to increase during the COVID-19 pandemic.

The growing demand for personalized medications has increased R&D spending, and technological advancements in plasma components such as immune serum globulin, which have advantages such as higher yield, lower cost, and faster throughput, are driving market growth. On the other hand, immunoglobulins generated from plasma are being employed more frequently for a variety of clinical conditions, including autoimmune and inflammatory illnesses. Therapies including Ceruloplasmin, IgA, and Plasmin have received significant funding from the plasma fractionation sector. Additionally, the industry will receive a boost from booming investments in innovation and technology developments that result in efficient and affordable methods for fractionating proteins. thus, propelling the market's growth.

For companies operating market-related businesses, the market offers a lot of opportunities. In addition, the global and regional market participants are actively implementing organic and inorganic development strategies as a result of the market's favorable expansion. As a result, it is anticipated that the market will draw more notable investments during the forecast period. For instance, in January 2022, the eighth plasma collection facility in the Czech Republic was opened by Biotest AG. The national public health authority, SUKL, granted the company an operating license for these centers.

Plasma Fractionation Market Report Highlights:

  • The immunoglobulins segment dominated the market in terms of revenue share of 63.2% in 2024 and is anticipated to grow at the fastest CAGR of 9.1%. fueled by its widespread use in treating immune deficiencies, autoimmune diseases, and neurological disorders.
  • The chromatography segment dominated the market and accounted for a 33.7% share in 2024. The utilization of industrial-scale chromatographic fractionation as well as purification techniques for plasma fractionation has increased recently.
  • The neurology segment held the largest revenue share of 30.0% in 2024, driven by the increasing recognition of plasma-derived therapies for neurological disorders. Conditions such as multiple sclerosis, Guillain-Barre syndrome, and chronic inflammatory demyelinating polyneuropathy are increasingly being treated with therapies like intravenous immunoglobulin (IVIg) and plasmapheresis.
  • The hospitals and clinics dominated the market with the largest revenue share of 53.4% in 2024 and are expected to grow at the fastest CAGR of 9.0% over the forecast period. This is driven by the increasing demand for plasma-derived therapies in various medical applications.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Market Definitions
    • 1.2.1. Product Segment
    • 1.2.2. Method Segment
    • 1.2.3. Application Segment
    • 1.2.4. End use Segment
  • 1.3. Information analysis
    • 1.3.1. Market formulation & data visualization
  • 1.4. Data validation & publishing
  • 1.5. Information Procurement
    • 1.5.1. Primary Research
  • 1.6. Information or Data Analysis
  • 1.7. Market Formulation & Validation
  • 1.8. Market Model
  • 1.9. Total Market: CAGR Calculation
  • 1.10. Objectives
    • 1.10.1. Objective 1
    • 1.10.2. Objective 2

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Snapshot
  • 2.3. Competitive Insights Landscape

Chapter 3. Plasma Fractionation Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook.
  • 3.2. Market Dynamics
    • 3.2.1. Market driver analysis
      • 3.2.1.1. Growing Demand For Advanced Treatment Options To Boost Market Growth
      • 3.2.1.2. Growing Use Of Immunoglobulins In Various Therapeutic Areas
    • 3.2.2. Market restraint analysis
      • 3.2.2.1. Stringent Regulatory Policies
  • 3.3. Plasma Fractionation Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
    • 3.3.2. PESTEL Analysis
    • 3.3.3. COVID-19 Impact Analysis

Chapter 4. Plasma Fractionation Market: Product Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. Global Plasma Fractionation Market Product Movement Analysis
  • 4.3. Global Plasma Fractionation Market Size & Trend Analysis, by Product, 2018 to 2030 (USD Billion)
  • 4.4. Albumin
    • 4.4.1. Albumin market estimates and forecasts 2018 to 2030 (USD Billion)
  • 4.5. Immunoglobulins
    • 4.5.1. Immunoglobulins market estimates and forecasts 2018 to 2030 (USD Billion)
    • 4.5.2. Intravenous immunoglobulins
      • 4.5.2.1. Intravenous immunoglobulins market estimates and forecasts 2018 to 2030 (USD Billion)
    • 4.5.3. Subcutaneous immunoglobulins
      • 4.5.3.1. Subcutaneous immunoglobulins market estimates and forecasts 2018 to 2030 (USD Billion)
    • 4.5.4. Other immunoglobulins
      • 4.5.4.1. Other immunoglobulins market estimates and forecasts 2018 to 2030 (USD Billion)
  • 4.6. Coagulation Factors
    • 4.6.1. Coagulation factors market estimates and forecasts 2018 to 2030 (USD Billion)
    • 4.6.2. Factor VIII
      • 4.6.2.1. Factor VIII market estimates and forecasts 2018 to 2030 (USD Billion)
    • 4.6.3. Factor IX
      • 4.6.3.1. Factor IX market estimates and forecasts 2018 to 2030 (USD Billion)
    • 4.6.4. VON WILLEBRAND factor
      • 4.6.4.1. VON WILLEBRAND factor market estimates and forecasts 2018 to 2030 (USD Billion)
    • 4.6.5. Prothrombin complex concentrates
      • 4.6.5.1. Prothrombin complex concentrates market estimates and forecasts 2018 to 2030 (USD Billion)
    • 4.6.6. Fibrinogen concentrates
      • 4.6.6.1. Fibrinogen concentrates market estimates and forecasts 2018 to 2030 (USD Billion)
    • 4.6.7. Others
      • 4.6.7.1. Others factor market estimates and forecasts 2018 to 2030 (USD Billion)
  • 4.7. Protease inhibitors
    • 4.7.1. Protease inhibitors market estimates and forecasts 2018 to 2030 (USD Billion)
  • 4.8. Others
    • 4.8.1. Others market estimates and forecasts 2018 to 2030 (USD Billion)

Chapter 5. Plasma Fractionation Market: Method Estimates & Trend Analysis

  • 5.1. Segment Dashboard
  • 5.2. Global Plasma Fractionation Market Method Movement Analysis
  • 5.3. Global Plasma Fractionation Market Size & Trend Analysis, by Method, 2018 to 2030 (USD Billion)
  • 5.4. Centrifugation
    • 5.4.1. Centrifugation market estimates and forecasts 2018 to 2030 (USD Billion)
  • 5.5. Depth Filtration
    • 5.5.1. Depth filtration market estimates and forecasts 2018 to 2030 (USD Billion)
  • 5.6. Chromatography
    • 5.6.1. Chromatography market estimates and forecasts 2018 to 2030 (USD Billion)
  • 5.7. Others
    • 5.7.1. Others market estimates and forecasts 2018 to 2030 (USD Billion)

Chapter 6. Plasma Fractionation Market: Application Estimates & Trend Analysis

  • 6.1. Segment Dashboard
  • 6.2. Global Plasma Fractionation Market Application Movement Analysis
  • 6.3. Global Plasma Fractionation Market Size & Trend Analysis, by Application, 2018 to 2030 (USD Billion)
  • 6.4. Neurology
    • 6.4.1. Neurology market estimates and forecasts 2018 to 2030 (USD Billion)
  • 6.5. Hematology
    • 6.5.1. Hematology market estimates and forecasts 2018 to 2030 (USD Billion)
  • 6.6. Oncology
    • 6.6.1. Oncology market estimates and forecasts 2018 to 2030 (USD Billion)
  • 6.7. Immunology
    • 6.7.1. Immunology market estimates and forecasts 2018 to 2030 (USD Billion)
  • 6.8. Pulmonology
    • 6.8.1. Pulmonology market estimates and forecasts 2018 to 2030 (USD Billion)
  • 6.9. Others
    • 6.9.1. Others market estimates and forecasts 2018 to 2030 (USD Billion)

Chapter 7. Plasma Fractionation Market: End-use Estimates & Trend Analysis

  • 7.1. Segment Dashboard
  • 7.2. Global Plasma Fractionation Market End-use Movement Analysis
  • 7.3. Global Plasma Fractionation Market Size & Trend Analysis, by End-use, 2018 to 2030 (USD Billion)
  • 7.4. Hospitals & Clinics
    • 7.4.1. Hospitals & clinics market estimates and forecasts 2018 to 2030 (USD Billion)
  • 7.5. Clinical Research
    • 7.5.1. Clinical research market estimates and forecasts 2018 to 2030 (USD Billion)
  • 7.6. Others
    • 7.6.1. Others market estimates and forecasts 2018 to 2030 (USD Billion)

Chapter 8. Plasma Fractionation Market: Regional Estimates & Trend Analysis

  • 8.1. Regional Market Share Analysis, 2024 & 2030
  • 8.2. Regional Market Dashboard
  • 8.3. Market Size & Forecasts Trend Analysis, 2018 to 2030:
  • 8.4. North America
    • 8.4.1. U.S.
      • 8.4.1.1. Key country dynamics
      • 8.4.1.2. Competitive scenario
      • 8.4.1.3. Regulatory framework
      • 8.4.1.4. U.S. market estimates and forecasts 2018 to 2030 (USD Billion)
    • 8.4.2. Canada
      • 8.4.2.1. Key country dynamics
      • 8.4.2.2. Competitive scenario
      • 8.4.2.3. Regulatory framework
      • 8.4.2.4. Canada market estimates and forecasts 2018 to 2030 (USD Billion)
    • 8.4.3. Mexico
      • 8.4.3.1. Key country dynamics
      • 8.4.3.2. Competitive scenario
      • 8.4.3.3. Regulatory framework
      • 8.4.3.4. Mexico market estimates and forecasts 2018 to 2030 (USD Billion)
  • 8.5. Europe
    • 8.5.1. UK
      • 8.5.1.1. Key country dynamics
      • 8.5.1.2. Competitive scenario
      • 8.5.1.3. Regulatory framework
      • 8.5.1.4. UK market estimates and forecasts 2018 to 2030 (USD Billion)
    • 8.5.2. Germany
      • 8.5.2.1. Key country dynamics
      • 8.5.2.2. Competitive scenario
      • 8.5.2.3. Regulatory framework
      • 8.5.2.4. Germany market estimates and forecasts 2018 to 2030 (USD Billion)
    • 8.5.3. France
      • 8.5.3.1. Key country dynamics
      • 8.5.3.2. Competitive scenario
      • 8.5.3.3. Regulatory framework
      • 8.5.3.4. France market estimates and forecasts 2018 to 2030 (USD Billion)
    • 8.5.4. Italy
      • 8.5.4.1. Key country dynamics
      • 8.5.4.2. Competitive scenario
      • 8.5.4.3. Regulatory framework
      • 8.5.4.4. Italy market estimates and forecasts 2018 to 2030 (USD Billion)
    • 8.5.5. Spain
      • 8.5.5.1. Key country dynamics
      • 8.5.5.2. Competitive scenario
      • 8.5.5.3. Regulatory framework
      • 8.5.5.4. Spain market estimates and forecasts 2018 to 2030 (USD Billion)
    • 8.5.6. Denmark
      • 8.5.6.1. Key country dynamics
      • 8.5.6.2. Competitive scenario
      • 8.5.6.3. Denmark market estimates and forecasts 2018 to 2030 (USD Billion)
    • 8.5.7. Sweden
      • 8.5.7.1. Key country dynamics
      • 8.5.7.2. Competitive scenario
      • 8.5.7.3. Regulatory framework
      • 8.5.7.4. Sweden market estimates and forecasts 2018 to 2030 (USD Billion)
    • 8.5.8. Norway
      • 8.5.8.1. Key country dynamics
      • 8.5.8.2. Competitive scenario
      • 8.5.8.3. Regulatory framework
      • 8.5.8.4. Norway market estimates and forecasts 2018 to 2030 (USD Billion)
  • 8.6. Asia Pacific
    • 8.6.1. Japan
      • 8.6.1.1. Key country dynamics
      • 8.6.1.2. Competitive scenario
      • 8.6.1.3. Regulatory framework
      • 8.6.1.4. Japan market estimates and forecasts 2018 to 2030 (USD Billion)
    • 8.6.2. China
      • 8.6.2.1. Key country dynamics
      • 8.6.2.2. Competitive scenario
      • 8.6.2.3. Regulatory framework
      • 8.6.2.4. China market estimates and forecasts 2018 to 2030 (USD Billion)
    • 8.6.3. India
      • 8.6.3.1. Key country dynamics
      • 8.6.3.2. Competitive scenario
      • 8.6.3.3. Regulatory framework
      • 8.6.3.4. India market estimates and forecasts 2018 to 2030 (USD Billion)
    • 8.6.4. Australia
      • 8.6.4.1. Key country dynamics
      • 8.6.4.2. Competitive scenario
      • 8.6.4.3. Regulatory framework
      • 8.6.4.4. Australia market estimates and forecasts 2018 to 2030 (USD Billion)
    • 8.6.5. South Korea
      • 8.6.5.1. Key country dynamics
      • 8.6.5.2. Competitive scenario
      • 8.6.5.3. Regulatory framework
      • 8.6.5.4. South Korea market estimates and forecasts 2018 to 2030 (USD Billion)
    • 8.6.6. Thailand
      • 8.6.6.1. Key country dynamics
      • 8.6.6.2. Competitive scenario
      • 8.6.6.3. Regulatory framework
      • 8.6.6.4. Thailand market estimates and forecasts 2018 to 2030 (USD Billion)
  • 8.7. Latin America
    • 8.7.1. Brazil
      • 8.7.1.1. Key country dynamics
      • 8.7.1.2. Competitive scenario
      • 8.7.1.3. Regulatory framework
      • 8.7.1.4. Brazil market estimates and forecasts 2018 to 2030 (USD Billion)
    • 8.7.2. Argentina
      • 8.7.2.1. Key country dynamics
      • 8.7.2.2. Competitive scenario
      • 8.7.2.3. Regulatory framework
      • 8.7.2.4. Argentina market estimates and forecasts 2018 to 2030 (USD Billion)
  • 8.8. MEA
    • 8.8.1. South Africa
      • 8.8.1.1. Key country dynamics
      • 8.8.1.2. Competitive scenario
      • 8.8.1.3. Regulatory framework
      • 8.8.1.4. South Africa market estimates and forecasts 2018 to 2030 (USD Billion)
    • 8.8.2. Saudi Arabia
      • 8.8.2.1. Key country dynamics
      • 8.8.2.2. Competitive scenario
      • 8.8.2.3. Saudi Arabia market estimates and forecasts 2018 to 2030 (USD Billion)
    • 8.8.3. UAE
      • 8.8.3.1. Key country dynamics
      • 8.8.3.2. Competitive scenario
      • 8.8.3.3. Regulatory framework
      • 8.8.3.4. UAE market estimates and forecasts 2018 to 2030 (USD Billion)
    • 8.8.4. Kuwait
      • 8.8.4.1. Key country dynamics
      • 8.8.4.2. Competitive scenario
      • 8.8.4.3. Regulatory framework
      • 8.8.4.4. Kuwait market estimates and forecasts 2018 to 2030 (USD Billion)

Chapter 9. Competitive Landscape

  • 9.1. Company/Competition Categorization
  • 9.2. Strategy Mapping
  • 9.3. Company Market Position Analysis, 2024
  • 9.4. Company Profiles/Listing
    • 9.4.1. Grifols S.A.
      • 9.4.1.1. Company overview
      • 9.4.1.2. Financial performance
      • 9.4.1.3. Product benchmarking
      • 9.4.1.4. Strategic initiatives
    • 9.4.2. CSL Limited
      • 9.4.2.1. Company overview
      • 9.4.2.2. Financial performance
      • 9.4.2.3. Product benchmarking
      • 9.4.2.4. Strategic initiatives
    • 9.4.3. Takeda Pharmaceutical Company Limited
      • 9.4.3.1. Company overview
      • 9.4.3.2. Financial performance
      • 9.4.3.3. Product benchmarking
      • 9.4.3.4. Strategic initiatives
    • 9.4.4. Octapharma AG
      • 9.4.4.1. Company overview
      • 9.4.4.2. Financial performance
      • 9.4.4.3. Product benchmarking
      • 9.4.4.4. Strategic initiatives
    • 9.4.5. Kedrion S.p.A
      • 9.4.5.1. Company overview
      • 9.4.5.2. Financial performance
      • 9.4.5.3. Product benchmarking
      • 9.4.5.4. Strategic initiatives
    • 9.4.6. LFB S.A.
      • 9.4.6.1. Company overview
      • 9.4.6.2. Financial performance
      • 9.4.6.3. Product benchmarking
      • 9.4.6.4. Strategic initiatives
    • 9.4.7. Biotest AG
      • 9.4.7.1. Company overview
      • 9.4.7.2. Financial performance
      • 9.4.7.3. Product benchmarking
      • 9.4.7.4. Strategic initiatives
    • 9.4.8. Sanquin
      • 9.4.8.1. Company overview
      • 9.4.8.2. Financial performance
      • 9.4.8.3. Product benchmarking
      • 9.4.8.4. Strategic initiatives
    • 9.4.9. Bio Products Laboratory Ltd.
      • 9.4.9.1. Company overview
      • 9.4.9.2. Financial performance
      • 9.4.9.3. Product benchmarking
      • 9.4.9.4. Strategic initiatives
    • 9.4.10. Intas Pharmaceuticals Ltd
      • 9.4.10.1. Company overview
      • 9.4.10.2. Financial performance
      • 9.4.10.3. Product benchmarking
      • 9.4.10.4. Strategic initiatives

List of Tables

  • Table 1 List of abbreviation
  • Table 2 Global plasma fractionation market, by region, 2018 - 2030 (USD Billion)
  • Table 3 Global plasma fractionation market, by product, 2018 - 2030 (USD Billion)
  • Table 4 Global plasma fractionation market, by method, 2018 - 2030 (USD Billion)
  • Table 5 Global plasma fractionation market, by application, 2018 - 2030 (USD Billion)
  • Table 6 Global plasma fractionation market, by end-use, 2018 - 2030 (USD Billion)
  • Table 7 North America plasma fractionation market, by country, 2018 - 2030 (USD Billion)
  • Table 8 North America plasma fractionation market, by product, 2018 - 2030 (USD Billion)
  • Table 9 North America plasma fractionation market, by method, 2018 - 2030 (USD Billion)
  • Table 10 North America plasma fractionation market, by application, 2018 - 2030 (USD Billion)
  • Table 11 North America plasma fractionation market, by end-use, 2018 - 2030 (USD Billion)
  • Table 12 U.S. plasma fractionation market, by product, 2018 - 2030 (USD Billion)
  • Table 13 U.S. plasma fractionation market, by method, 2018 - 2030 (USD Billion)
  • Table 14 U.S. plasma fractionation market, by application, 2018 - 2030 (USD Billion)
  • Table 15 U.S. plasma fractionation market, by end-use, 2018 - 2030 (USD Billion)
  • Table 16 Canada plasma fractionation market, by product, 2018 - 2030 (USD Billion)
  • Table 17 Canada plasma fractionation market, by method, 2018 - 2030 (USD Billion)
  • Table 18 Canada plasma fractionation market, by application, 2018 - 2030 (USD Billion)
  • Table 19 Canada plasma fractionation market, by end-use, 2018 - 2030 (USD Billion)
  • Table 20 Mexico plasma fractionation market, by product, 2018 - 2030 (USD Billion)
  • Table 21 Mexico plasma fractionation market, by method, 2018 - 2030 (USD Billion)
  • Table 22 Mexico plasma fractionation market, by application, 2018 - 2030 (USD Billion)
  • Table 23 Mexico plasma fractionation market, by end-use, 2018 - 2030 (USD Billion)
  • Table 24 Europe plasma fractionation market, by country, 2018 - 2030 (USD Billion)
  • Table 25 Europe plasma fractionation market, by product, 2018 - 2030 (USD Billion)
  • Table 26 Europe plasma fractionation market, by method, 2018 - 2030 (USD Billion)
  • Table 27 Europe plasma fractionation market, by application, 2018 - 2030 (USD Billion)
  • Table 28 Europe plasma fractionation market, by end-use, 2018 - 2030 (USD Billion)
  • Table 29 UK plasma fractionation market, by product, 2018 - 2030 (USD Billion)
  • Table 30 UK plasma fractionation market, by method, 2018 - 2030 (USD Billion)
  • Table 31 UK plasma fractionation market, by application, 2018 - 2030 (USD Billion)
  • Table 32 UK plasma fractionation market, by end-use, 2018 - 2030 (USD Billion)
  • Table 33 Germany plasma fractionation market, by product, 2018 - 2030 (USD Billion)
  • Table 34 Germany plasma fractionation market, by method, 2018 - 2030 (USD Billion)
  • Table 35 Germany plasma fractionation market, by application, 2018 - 2030 (USD Billion)
  • Table 36 Germany plasma fractionation market, by end-use, 2018 - 2030 (USD Billion)
  • Table 37 France plasma fractionation market, by product, 2018 - 2030 (USD Billion)
  • Table 38 France plasma fractionation market, by method, 2018 - 2030 (USD Billion)
  • Table 39 France plasma fractionation market, by application, 2018 - 2030 (USD Billion)
  • Table 40 France plasma fractionation market, by end-use, 2018 - 2030 (USD Billion)
  • Table 41 Italy plasma fractionation market, by product, 2018 - 2030 (USD Billion)
  • Table 42 Italy plasma fractionation market, by method, 2018 - 2030 (USD Billion)
  • Table 43 Italy plasma fractionation market, by application, 2018 - 2030 (USD Billion)
  • Table 44 Italy plasma fractionation market, by end-use, 2018 - 2030 (USD Billion)
  • Table 45 Spain plasma fractionation market, by product, 2018 - 2030 (USD Billion)
  • Table 46 Spain plasma fractionation market, by method, 2018 - 2030 (USD Billion)
  • Table 47 Spain plasma fractionation market, by application, 2018 - 2030 (USD Billion)
  • Table 48 Spain plasma fractionation market, by end-use, 2018 - 2030 (USD Billion)
  • Table 49 Denmark plasma fractionation market, by product, 2018 - 2030 (USD Billion)
  • Table 50 Denmark plasma fractionation market, by method, 2018 - 2030 (USD Billion)
  • Table 51 Denmark plasma fractionation market, by application, 2018 - 2030 (USD Billion)
  • Table 52 Denmark plasma fractionation market, by end-use, 2018 - 2030 (USD Billion)
  • Table 53 Sweden plasma fractionation market, by product, 2018 - 2030 (USD Billion)
  • Table 54 Sweden plasma fractionation market, by method, 2018 - 2030 (USD Billion)
  • Table 55 Sweden plasma fractionation market, by application, 2018 - 2030 (USD Billion)
  • Table 56 Sweden plasma fractionation market, by end-use, 2018 - 2030 (USD Billion)
  • Table 57 Norway plasma fractionation market, by product, 2018 - 2030 (USD Billion)
  • Table 58 Norway plasma fractionation market, by method, 2018 - 2030 (USD Billion)
  • Table 59 Norway plasma fractionation market, by application, 2018 - 2030 (USD Billion)
  • Table 60 Norway plasma fractionation market, by end-use, 2018 - 2030 (USD Billion)
  • Table 61 Asia Pacific plasma fractionation market, by country, 2018 - 2030 (USD Billion)
  • Table 62 Asia Pacific plasma fractionation market, by product, 2018 - 2030 (USD Billion)
  • Table 63 Asia Pacific plasma fractionation market, by method, 2018 - 2030 (USD Billion)
  • Table 64 Asia Pacific plasma fractionation market, by application, 2018 - 2030 (USD Billion)
  • Table 65 Asia Pacific plasma fractionation market, by end-use, 2018 - 2030 (USD Billion)
  • Table 66 Japan plasma fractionation market, by product, 2018 - 2030 (USD Billion)
  • Table 67 Japan plasma fractionation market, by method, 2018 - 2030 (USD Billion)
  • Table 68 Japan plasma fractionation market, by application, 2018 - 2030 (USD Billion)
  • Table 69 Japan plasma fractionation market, by end-use, 2018 - 2030 (USD Billion)
  • Table 70 China plasma fractionation market, by product, 2018 - 2030 (USD Billion)
  • Table 71 China plasma fractionation market, by application, 2018 - 2030 (USD Billion)
  • Table 72 China plasma fractionation market, by method, 2018 - 2030 (USD Billion)
  • Table 73 China plasma fractionation market, by end-use, 2018 - 2030 (USD Billion)
  • Table 74 India plasma fractionation market, by product, 2018 - 2030 (USD Billion)
  • Table 75 India plasma fractionation market, by method, 2018 - 2030 (USD Billion)
  • Table 76 India plasma fractionation market, by application, 2018 - 2030 (USD Billion)
  • Table 77 India plasma fractionation market, by end-use, 2018 - 2030 (USD Billion)
  • Table 78 Australia plasma fractionation market, by product, 2018 - 2030 (USD Billion)
  • Table 79 Australia plasma fractionation market, by method, 2018 - 2030 (USD Billion)
  • Table 80 Australia plasma fractionation market, by application, 2018 - 2030 (USD Billion)
  • Table 81 Australia plasma fractionation market, by end-use, 2018 - 2030 (USD Billion)
  • Table 82 South Korea plasma fractionation market, by product, 2018 - 2030 (USD Billion)
  • Table 83 South Korea plasma fractionation market, by method, 2018 - 2030 (USD Billion)
  • Table 84 South Korea plasma fractionation market, by application, 2018 - 2030 (USD Billion)
  • Table 85 South Korea plasma fractionation market, by end-use, 2018 - 2030 (USD Billion)
  • Table 86 Thailand plasma fractionation market, by product, 2018 - 2030 (USD Billion)
  • Table 87 Thailand plasma fractionation market, by method, 2018 - 2030 (USD Billion)
  • Table 88 Thailand plasma fractionation market, by application, 2018 - 2030 (USD Billion)
  • Table 89 Thailand plasma fractionation market, by end-use, 2018 - 2030 (USD Billion)
  • Table 90 Latin America plasma fractionation market, by country, 2018 - 2030 (USD Billion)
  • Table 91 Latin America plasma fractionation market, by product, 2018 - 2030 (USD Billion)
  • Table 92 Latin America plasma fractionation market, by method, 2018 - 2030 (USD Billion)
  • Table 93 Latin America plasma fractionation market, by application, 2018 - 2030 (USD Billion)
  • Table 94 Latin America plasma fractionation market, by end-use, 2018 - 2030 (USD Billion)
  • Table 95 Brazil plasma fractionation market, by product, 2018 - 2030 (USD Billion)
  • Table 96 Brazil plasma fractionation market, by method, 2018 - 2030 (USD Billion)
  • Table 97 Brazil plasma fractionation market, by application, 2018 - 2030 (USD Billion)
  • Table 98 Brazil plasma fractionation market, by end-use, 2018 - 2030 (USD Billion)
  • Table 99 Argentina plasma fractionation market, by product, 2018 - 2030 (USD Billion)
  • Table 100 Argentina plasma fractionation market, by method, 2018 - 2030 (USD Billion)
  • Table 101 Argentina plasma fractionation market, by application, 2018 - 2030 (USD Billion)
  • Table 102 Argentina plasma fractionation market, by end-use, 2018 - 2030 (USD Billion)
  • Table 103 MEA plasma fractionation market, by country, 2018 - 2030 (USD Billion)
  • Table 104 MEA plasma fractionation market, by product, 2018 - 2030 (USD Billion)
  • Table 105 MEA plasma fractionation market, by method, 2018 - 2030 (USD Billion)
  • Table 106 MEA plasma fractionation market, by application, 2018 - 2030 (USD Billion)
  • Table 107 MEA plasma fractionation market, by end-use, 2018 - 2030 (USD Billion)
  • Table 108 South Africa plasma fractionation market, by product, 2018 - 2030 (USD Billion)
  • Table 109 South Africa plasma fractionation market, by method, 2018 - 2030 (USD Billion)
  • Table 110 South Africa plasma fractionation market, by application, 2018 - 2030 (USD Billion)
  • Table 111 South Africa plasma fractionation market, by end-use, 2018 - 2030 (USD Billion)
  • Table 112 Saudi Arabia plasma fractionation market, by product, 2018 - 2030 (USD Billion)
  • Table 113 Saudi Arabia plasma fractionation market, by method, 2018 - 2030 (USD Billion)
  • Table 114 Saudi Arabia plasma fractionation market, by application, 2018 - 2030 (USD Billion)
  • Table 115 Saudi Arabia plasma fractionation market, by end-use, 2018 - 2030 (USD Billion)
  • Table 116 UAE plasma fractionation market, by product, 2018 - 2030 (USD Billion)
  • Table 117 UAE plasma fractionation market, by method, 2018 - 2030 (USD Billion)
  • Table 118 UAE plasma fractionation market, by application, 2018 - 2030 (USD Billion)
  • Table 119 UAE plasma fractionation market, by end-use, 2018 - 2030 (USD Billion)
  • Table 120 Kuwait plasma fractionation market, by product, 2018 - 2030 (USD Billion)
  • Table 121 Kuwait plasma fractionation market, by method, 2018 - 2030 (USD Billion)
  • Table 122 Kuwait plasma fractionation market, by application, 2018 - 2030 (USD Billion)
  • Table 123 Kuwait plasma fractionation market, by end-use, 2018 - 2030 (USD Billion)

List of Figures

  • Fig. 1 Plasma fractionation market segmentation
  • Fig. 2 Data analysis models
  • Fig. 3 Market formulation and validation
  • Fig. 4 Data validating & publishing
  • Fig. 5 Market research process
  • Fig. 6 Information procurement
  • Fig. 7 Primary research
  • Fig. 8 Value-chain-based sizing & forecasting
  • Fig. 9 QFD modelling for market share assessment
  • Fig. 10 Market formulation & validation
  • Fig. 11 Commodity flow analysis
  • Fig. 12 Market outlook
  • Fig. 13 Segment snapshot-1
  • Fig. 14 Segment snapshot-2
  • Fig. 15 Competitive landscape snapshot
  • Fig. 16 Market trends & outlook
  • Fig. 17 Porter's five force analysis
  • Fig. 18 PESTEL analysis
  • Fig. 19 Plasma fractionation market: Product outlook key takeaways
  • Fig. 20 Plasma fractionation market: Product movement analysis
  • Fig. 21 Albumin market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 22 Immunoglobulins market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 23 Intravenous immunoglobulins market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 24 Subcutaneous immunoglobulins market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 25 Other immunoglobulins market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 26 Coagulation Factors market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 27 Factor VIII market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 28 Factor IX market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 29 VON WILLEBRAND factor market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 30 Prothrombin complex concentrates market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 31 Fibrinogen concentrates market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 32 Others market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 33 Protease inhibitors market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 34 Others market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 35 Plasma fractionation market: Method outlook key takeaways
  • Fig. 36 Plasma fractionation market: Method movement analysis
  • Fig. 37 Centrifugation market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 38 Depth Filtration market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 39 Chromatography market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 40 Others market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 41 Plasma fractionation market: Application outlook key takeaways
  • Fig. 42 Plasma fractionation market: Application movement analysis
  • Fig. 43 Neurology market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 44 Hematology market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 45 Oncology market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 46 Immunology market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 47 Pulmonology market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 48 Others market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 49 Plasma fractionation market: End-use outlook key takeaways
  • Fig. 50 Plasma fractionation market: End-use movement analysis
  • Fig. 51 Hospitals & clinics market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 52 Clinical research market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 53 Others market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 54 Regional marketplace outlook, 2024 & 2030 (USD Billion)
  • Fig. 55 Regional marketplace: Key takeaways
  • Fig. 56 North America plasma fractionation market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 57 Key country dynamics
  • Fig. 58 U.S. plasma fractionation market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 59 Key country dynamics
  • Fig. 60 Canada plasma fractionation market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 61 Key country dynamics
  • Fig. 62 Mexico plasma fractionation market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 63 Europe plasma fractionation market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 64 Key country dynamics
  • Fig. 65 UK plasma fractionation market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 66 Key country dynamics
  • Fig. 67 Germany plasma fractionation market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 68 Key country dynamics
  • Fig. 69 France plasma fractionation market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 70 Key country dynamics
  • Fig. 71 Spain plasma fractionation market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 72 Key country dynamics
  • Fig. 73 Italy plasma fractionation market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 74 Key country dynamics
  • Fig. 75 Denmark plasma fractionation market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 76 Key country dynamics
  • Fig. 77 Sweden plasma fractionation market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 78 Key country dynamics
  • Fig. 79 Norway plasma fractionation market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 80 Asia Pacific plasma fractionation market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 81 Key country dynamics
  • Fig. 82 Japan plasma fractionation market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 83 Key country dynamics
  • Fig. 84 China plasma fractionation market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 85 Key country dynamics
  • Fig. 86 India plasma fractionation market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 87 Key country dynamics
  • Fig. 88 Australia plasma fractionation market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 89 Key country dynamics
  • Fig. 90 South Korea plasma fractionation market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 91 Key country dynamics
  • Fig. 92 Thailand plasma fractionation market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 93 Key country dynamics
  • Fig. 94 Market participant categorization
  • Fig. 95 Plasma fractionation market position analysis, 2024
  • Fig. 96 Strategic framework